Investigating Domain-Specific Cognitive Impairment Among Patients With Multiple Sclerosis Using Touchscreen Cognitive Testing in Routine Clinical Care

Cognitive dysfunction is present in up to 70% of patients with multiple sclerosis (MS) and has been reported at all stages and in all subtypes of the disease. These deficits have been reported across a variety of cognitive domains, but are generally under-recognized and incompletely evaluated in rou...

Full description

Bibliographic Details
Main Authors: Jack Cotter, Nethmi Vithanage, Shuna Colville, Dawn Lyle, Denise Cranley, Francesca Cormack, Jennifer H. Barnett, Katy Murray, Suvankar Pal
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-05-01
Series:Frontiers in Neurology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fneur.2018.00331/full
_version_ 1811315021130498048
author Jack Cotter
Nethmi Vithanage
Shuna Colville
Dawn Lyle
Denise Cranley
Francesca Cormack
Jennifer H. Barnett
Jennifer H. Barnett
Katy Murray
Katy Murray
Katy Murray
Suvankar Pal
Suvankar Pal
Suvankar Pal
author_facet Jack Cotter
Nethmi Vithanage
Shuna Colville
Dawn Lyle
Denise Cranley
Francesca Cormack
Jennifer H. Barnett
Jennifer H. Barnett
Katy Murray
Katy Murray
Katy Murray
Suvankar Pal
Suvankar Pal
Suvankar Pal
author_sort Jack Cotter
collection DOAJ
description Cognitive dysfunction is present in up to 70% of patients with multiple sclerosis (MS) and has been reported at all stages and in all subtypes of the disease. These deficits have been reported across a variety of cognitive domains, but are generally under-recognized and incompletely evaluated in routine clinical practice. The aim of this study was to investigate the spectrum of cognitive impairment in patients with MS presenting to a specialist MS clinic using the Cambridge Neuropsychological Test Automated Battery (CANTAB), administered on a touchscreen platform. Ninety MS patients completed computerized CANTAB tasks assessing working memory, executive function, processing speed, attention, and episodic memory. Scores were adjusted for age, sex, and level of education and classified as normal or impaired based on comparison with a large normative data pool. We also investigated the impact of clinical and demographic variables which could potentially influence cognitive performance including patient educational level (a proxy for cognitive reserve), disease status (duration, course, and severity of MS), and depression. CANTAB testing detected cognitive impairment in 40 patients (44% of the sample). The most frequently impaired domain was executive function, present in 55% of cognitively impaired individuals. Disease duration and severity were significantly associated with performance across various cognitive domains. Patients with depressive symptoms were also more likely to exhibit impaired processing speed. Results from this study confirm that cognitive impairment is common and occurs across a range of domains among MS patients attending routine clinical visits. CANTAB tasks provide a sensitive and practical approach to cognitive testing in MS patients as part of a holistic patient assessment.
first_indexed 2024-04-13T11:22:45Z
format Article
id doaj.art-1c3f85169f7749c3a0d827488f0c2530
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-04-13T11:22:45Z
publishDate 2018-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-1c3f85169f7749c3a0d827488f0c25302022-12-22T02:48:46ZengFrontiers Media S.A.Frontiers in Neurology1664-22952018-05-01910.3389/fneur.2018.00331366476Investigating Domain-Specific Cognitive Impairment Among Patients With Multiple Sclerosis Using Touchscreen Cognitive Testing in Routine Clinical CareJack Cotter0Nethmi Vithanage1Shuna Colville2Dawn Lyle3Denise Cranley4Francesca Cormack5Jennifer H. Barnett6Jennifer H. Barnett7Katy Murray8Katy Murray9Katy Murray10Suvankar Pal11Suvankar Pal12Suvankar Pal13Cambridge Cognition, Cambridge, United KingdomCollege of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United KingdomAnne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, United KingdomAnne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, United KingdomAnne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, United KingdomCambridge Cognition, Cambridge, United KingdomCambridge Cognition, Cambridge, United KingdomDepartment of Psychiatry, University of Cambridge, Cambridge, United KingdomAnne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, United KingdomForth Valley Royal Hospital, Larbert, United KingdomCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United KingdomAnne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, United KingdomForth Valley Royal Hospital, Larbert, United KingdomCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United KingdomCognitive dysfunction is present in up to 70% of patients with multiple sclerosis (MS) and has been reported at all stages and in all subtypes of the disease. These deficits have been reported across a variety of cognitive domains, but are generally under-recognized and incompletely evaluated in routine clinical practice. The aim of this study was to investigate the spectrum of cognitive impairment in patients with MS presenting to a specialist MS clinic using the Cambridge Neuropsychological Test Automated Battery (CANTAB), administered on a touchscreen platform. Ninety MS patients completed computerized CANTAB tasks assessing working memory, executive function, processing speed, attention, and episodic memory. Scores were adjusted for age, sex, and level of education and classified as normal or impaired based on comparison with a large normative data pool. We also investigated the impact of clinical and demographic variables which could potentially influence cognitive performance including patient educational level (a proxy for cognitive reserve), disease status (duration, course, and severity of MS), and depression. CANTAB testing detected cognitive impairment in 40 patients (44% of the sample). The most frequently impaired domain was executive function, present in 55% of cognitively impaired individuals. Disease duration and severity were significantly associated with performance across various cognitive domains. Patients with depressive symptoms were also more likely to exhibit impaired processing speed. Results from this study confirm that cognitive impairment is common and occurs across a range of domains among MS patients attending routine clinical visits. CANTAB tasks provide a sensitive and practical approach to cognitive testing in MS patients as part of a holistic patient assessment.http://journal.frontiersin.org/article/10.3389/fneur.2018.00331/fullmultiple sclerosiscognitionCambridge Neuropsychological Test Automated Batterycomputerized testingneuropsychological assessment
spellingShingle Jack Cotter
Nethmi Vithanage
Shuna Colville
Dawn Lyle
Denise Cranley
Francesca Cormack
Jennifer H. Barnett
Jennifer H. Barnett
Katy Murray
Katy Murray
Katy Murray
Suvankar Pal
Suvankar Pal
Suvankar Pal
Investigating Domain-Specific Cognitive Impairment Among Patients With Multiple Sclerosis Using Touchscreen Cognitive Testing in Routine Clinical Care
Frontiers in Neurology
multiple sclerosis
cognition
Cambridge Neuropsychological Test Automated Battery
computerized testing
neuropsychological assessment
title Investigating Domain-Specific Cognitive Impairment Among Patients With Multiple Sclerosis Using Touchscreen Cognitive Testing in Routine Clinical Care
title_full Investigating Domain-Specific Cognitive Impairment Among Patients With Multiple Sclerosis Using Touchscreen Cognitive Testing in Routine Clinical Care
title_fullStr Investigating Domain-Specific Cognitive Impairment Among Patients With Multiple Sclerosis Using Touchscreen Cognitive Testing in Routine Clinical Care
title_full_unstemmed Investigating Domain-Specific Cognitive Impairment Among Patients With Multiple Sclerosis Using Touchscreen Cognitive Testing in Routine Clinical Care
title_short Investigating Domain-Specific Cognitive Impairment Among Patients With Multiple Sclerosis Using Touchscreen Cognitive Testing in Routine Clinical Care
title_sort investigating domain specific cognitive impairment among patients with multiple sclerosis using touchscreen cognitive testing in routine clinical care
topic multiple sclerosis
cognition
Cambridge Neuropsychological Test Automated Battery
computerized testing
neuropsychological assessment
url http://journal.frontiersin.org/article/10.3389/fneur.2018.00331/full
work_keys_str_mv AT jackcotter investigatingdomainspecificcognitiveimpairmentamongpatientswithmultiplesclerosisusingtouchscreencognitivetestinginroutineclinicalcare
AT nethmivithanage investigatingdomainspecificcognitiveimpairmentamongpatientswithmultiplesclerosisusingtouchscreencognitivetestinginroutineclinicalcare
AT shunacolville investigatingdomainspecificcognitiveimpairmentamongpatientswithmultiplesclerosisusingtouchscreencognitivetestinginroutineclinicalcare
AT dawnlyle investigatingdomainspecificcognitiveimpairmentamongpatientswithmultiplesclerosisusingtouchscreencognitivetestinginroutineclinicalcare
AT denisecranley investigatingdomainspecificcognitiveimpairmentamongpatientswithmultiplesclerosisusingtouchscreencognitivetestinginroutineclinicalcare
AT francescacormack investigatingdomainspecificcognitiveimpairmentamongpatientswithmultiplesclerosisusingtouchscreencognitivetestinginroutineclinicalcare
AT jenniferhbarnett investigatingdomainspecificcognitiveimpairmentamongpatientswithmultiplesclerosisusingtouchscreencognitivetestinginroutineclinicalcare
AT jenniferhbarnett investigatingdomainspecificcognitiveimpairmentamongpatientswithmultiplesclerosisusingtouchscreencognitivetestinginroutineclinicalcare
AT katymurray investigatingdomainspecificcognitiveimpairmentamongpatientswithmultiplesclerosisusingtouchscreencognitivetestinginroutineclinicalcare
AT katymurray investigatingdomainspecificcognitiveimpairmentamongpatientswithmultiplesclerosisusingtouchscreencognitivetestinginroutineclinicalcare
AT katymurray investigatingdomainspecificcognitiveimpairmentamongpatientswithmultiplesclerosisusingtouchscreencognitivetestinginroutineclinicalcare
AT suvankarpal investigatingdomainspecificcognitiveimpairmentamongpatientswithmultiplesclerosisusingtouchscreencognitivetestinginroutineclinicalcare
AT suvankarpal investigatingdomainspecificcognitiveimpairmentamongpatientswithmultiplesclerosisusingtouchscreencognitivetestinginroutineclinicalcare
AT suvankarpal investigatingdomainspecificcognitiveimpairmentamongpatientswithmultiplesclerosisusingtouchscreencognitivetestinginroutineclinicalcare